These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15365312)

  • 1. Chronic ethanol enhances ectodomain shedding in T cells and monocytes.
    Zhao XJ; Oliver P; Song K; Schurr J; Zhang Z; Kolls JK
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1399-407. PubMed ID: 15365312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells.
    Zhang Z; Bagby GJ; Stoltz D; Oliver P; Schwarzenberger PO; Kolls JK
    Alcohol Clin Exp Res; 2001 Mar; 25(3):444-9. PubMed ID: 11290857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
    FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TNF-alpha processing and TACE-mediated ectodomain shedding by ethanol.
    Zhang Z; Cork J; Ye P; Lei D; Schwarzenberger PO; Summer WR; Shellito JE; Nelson S; Kolls JK
    J Leukoc Biol; 2000 Jun; 67(6):856-62. PubMed ID: 10857859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.
    Cope AP; Aderka D; Wallach D; Kahan M; Chu NR; Brennan FM; Feldmann M
    Immunology; 1995 Jan; 84(1):21-30. PubMed ID: 7890302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in TNF-alpha signal transduction in resistant human papillary thyroid carcinoma cells.
    Pang XP; Ross NS; Hershman JM
    Thyroid; 1996 Aug; 6(4):313-7. PubMed ID: 8875753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.
    Slowik MR; De Luca LG; Fiers W; Pober JS
    Am J Pathol; 1993 Dec; 143(6):1724-30. PubMed ID: 7504889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.
    Cope AP; Gibbons DL; Aderka D; Foxwell BM; Wallach D; Maini RN; Feldmann M; Brennan FM
    Cytokine; 1993 May; 5(3):205-12. PubMed ID: 8218932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding.
    Killock DJ; Ivetić A
    Biochem J; 2010 May; 428(2):293-304. PubMed ID: 20331435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inducibility of TNF-alpha production is different in the granulocytic and monocytic differentiated forms of wild type and CGD-mutant PLB-985 cells.
    Selmeczy Z; Szelényi J; Német K; Vizi ES
    Immunol Cell Biol; 2003 Dec; 81(6):472-9. PubMed ID: 14636244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia.
    Waage A; Liabakk N; Lien E; Lamvik J; Espevik T
    Blood; 1992 Nov; 80(10):2577-83. PubMed ID: 1384790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings.
    Bueno C; Rodriguez-Caballero A; García-Montero A; Pandiella A; Almeida J; Orfao A
    J Immunol Methods; 2002 Jun; 264(1-2):77-87. PubMed ID: 12191512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes.
    Borland G; Murphy G; Ager A
    J Biol Chem; 1999 Jan; 274(5):2810-5. PubMed ID: 9915814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression.
    Joyce DA; Kloda A; Steer JH
    Immunol Cell Biol; 1997 Aug; 75(4):345-50. PubMed ID: 9315475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of L-selectin mRNA in Jurkat cells. Opposing influences of calcium- and protein kinase C-dependent signaling pathways.
    Kaldjian EP; Stoolman LM
    J Immunol; 1995 May; 154(9):4351-62. PubMed ID: 7536769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells.
    Sippy BD; Hofman FM; Wright AD; He S; Ryan SJ; Hinton DR
    Exp Eye Res; 1996 Sep; 63(3):311-7. PubMed ID: 8943704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the surface expression of tumor necrosis factor alpha (TNFalpha) but not the p55 TNFalpha receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitors.
    Glaser KB; Pease L; Li J; Morgan DW
    Biochem Pharmacol; 1999 Feb; 57(3):291-302. PubMed ID: 9890556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.